TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics
Combined company will operate as TuHURA Biosciences, Inc. and advance pipeline of novel technologies to overcome resistance to cancer immunotherapy ...
Hosted on MSN4h
Lucid (NASDAQ:LCID) Is Outpacing Luxury EV Competitors, According to CEO
Lucid Group ($LCID) may be struggling right now, but according to CEO Peter Rawlinson, it is still outpacing many luxury EV ...
Albertsons gains amid Wells Fargo upgrade on `Plan B' if Kroger deal fails
Financial writer covers Albertsons (ACI) rise in premarket trading after Wells Fargo raises rating, citing value opportunity ...
Lucid Group’s Strategic Potential and Capital Needs Justify Hold Rating Amid Revenue Challenges and Production Ramp-Up
Bank of America Securities analyst John Murphy has reiterated their neutral stance on LCID stock, giving a Hold rating yesterday. John ...
Lucid Shares Sink on Stock Sale, Loss Warning
Lucid shares dropped after the electric-vehicle maker said it would shore up its finances by issuing new stock and warned of ...
thearabianpost14h
Saudi Investment in Lucid Fuels $1.67 Billion Stock Offering
Lucid Motors, the electric vehicle manufacturer backed by Saudi Arabia’s Public Investment Fund (PIF), is set to launch a ...
AltEnergy Acquisition (NASDAQ:AEAE) Stock Price Up 0.9% – Should You Buy?
AltEnergy Acquisition Corp. (NASDAQ:AEAE – Get Free Report) shares shot up 0.9% during trading on Thursday . The stock traded as high as $11.30 and last traded at $11.25. 2,542 shares were traded ...
B. Riley Predicts Altus Power’s Q3 Earnings (NYSE:AMPS)
Equities research analysts at B. Riley dropped their Q3 2024 earnings per share (EPS) estimates for shares of Altus Power in a research note issued on Wednesday, October 16th. B. Riley analyst R.